LDS/Medical Tests/Hereditary Hemolytic Anemia Gene Mutation Panel, NGS

Hereditary Hemolytic Anemia Gene Mutation Panel, NGS

Hereditary hemolytic anemia (HHA) is characterized by decreased red cell lifespan and anemia due to intrinsic RBC defects. Clinical presentation is highly variable and may include fatigue, jaundice/ scleral icterus, pigment gallstones, pallor and splenomegaly. Laboratory findings include decreased hemoglobin concentration, hematocrit, and RBC count. Depending on the type of red cell defect, blood smear abnormalities such as drepanocytes, spherocytes, elliptocytes, schistocytes, bite cells, stomatocytes, polychromasia, and target cells may be present. HHA is divided into three categories: hemogloblinopathies, erythrocyte membrane defects and enzyme deficiencies.

Hereditary spherocytosis (HS) is relatively rare disorder characterized by an abnormal RBC membrane cytoskeleton, resulting in irregular shape, increased fragility, and hemolysis. It is typically inherited in an autosomal dominant manner due to pathogenic variants in a membrane/cytoskeleton protein genes for ankyrin (ANK1), spectrin (SPTB & SPTA1), Band 3 (SLC4A1) or Band 4 (EPB42)genes. Abnormalities in spectrin and ankyrin account for the bulk of cases. In general, truncating variants in the SPTB gene are associated with autosomal dominant forms of HS, whereas missense variants are more commonly found in autosomal recessive forms. Most pathogenic variants reported to date in HS related genes are private truncating variants. About 30% of HS cases are de novo with no family history.

Red blood cell enzymopathies are caused by mutations in genes related red cell energy production. These disorders may be inherited in an autosomal recessive manner due to mutations in AK1, ALDOA, GCLC, GPI, GPX1, GSR, GSS, HK1, NT5C3A, PFKL, PFKM, PKLR, and TPI1 genes. They may also be inherited in an X-linked recessive manner due to mutations in either G6PD or PGK1 genes. Pathogenic variants in the G6PD (G-6-PD deficiency) and PKLR genes (pyruvate kinase deficiency) represent the most common red blood cell enzymopathies seen clinically. Missense mutations are the most frequent finding in the disorders accounting for ~85% and ~70% of cases respectively.

Congenital dyserythropoietic anemia (CDA) is a rare group of disorders characterized by anemia, ineffective erythropoiesis and multinucleated erythroblasts in the bone marrow. CDA may result from mutations in several genes and the specific gene(s) involved dictate the typical mode of inheritance. CDA is inherited as an autosomal recessive when due to mutations in CDAN1, C15ORF41, or SEC23B genes, it is inherited in an autosomal dominant fashion due to mutations in the KLF1 or KIF23 genes and in an X-linked recessive manner when caused by mutation in the GATA1 gene.

Hereditary xerocytosis (HX) or dehydrated stomatocytosis is caused by pathogenic variants in the PIEZO1 or KCNN4 genes that is inherited in an autosomal dominant manner. Mujtations in either of these genes results in loss of intracellular potassium and subsequent red cell osmotic dehydration.

Genetic testing can be helpful for differential diagnosis of intrinsic versus extrinsic forms of hemolytic anemia and for accurate diagnosis of intrinsic hereditary hemolytic anemias.

Panel Components

Although it depends on the laboratory and the clinical utility this panel uses targeted next-generation sequencing to evaluate for most common variants within genes: AK1, ALDOA, ANK1, C15ORF41, CD59, CDAN1, EPB41, EPB42, FANCA, FANCC, FANCG, G6PD, GATA1, GCLC, GPI, GSR, GSS, GYPC, HBB, HBD, HK1, HMOX1, KIF23, KLF1, NT5C3A, PFKM, PGK1, PIEZO1, PKLR, RHAG, RPS19, SEC23B, SLC2A1, SLC4A1, SPTA1, SPTB, STOM, TPI1, and UGT1A1 associated with hereditary hemolytic anemia.

  • Diagnostic confirmation of hereditary hemolytic anemia
  • Genetic evaluation for patients with a personal or family history suggestive of hereditary hemolytic anemias
  • As an aid diagnosis hydrops fetalis of unknown etiology in high risk pregnancies

Positive
At least one known pathogenic variant or mutation associated with hereditary hemolytic anemia should be detected in the tested genes. Pathogenic variants may include missense or truncating variants.

Negative
No pathogenic variant or mutation detected in the tested genes.

Negative for pathogenic variant or mutation in the tested genes

Next-Generation Sequencing (NGS), Conventional Sanger Sequencing.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 hours
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Complete blood count, Peripheral blood smear microscopic review, hemoglobin, Hematocrit, Iron/Transferrin levels, G6PD deficiency screen.
2-3 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login